Phosphorylated retinoblastoma is a biomarker of overall disease control and better progression-free survival of recurrent epithelial ovarian cancer patients treated with second-line topoisomerase inhibitor CPT-11 chemotherapy
-
Published:2018-12
Issue:6
Volume:7
Page:1682-1693
-
ISSN:2218-676X
-
Container-title:Translational Cancer Research
-
language:
-
Short-container-title:Transl. Cancer Res
Author:
Jiang Kui,Gao Guangyan,Yao Lulu
Publisher
AME Publishing Company
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology